Feasibility and advantage of adding 131I-MIBG to 90Y-DOTATOC for treatment of patients with advanced stage neuroendocrine tumors

Overview of attention for article published in EJNMMI Research, September 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Altmetric has seen 1 X post from an account with 2,986 followers.

ARTICLE: Feasibility and advantage of adding 131I-MIBG to 90Y-DOTATOC for treatment of patients with advanced... http://t.co/6NSNsyTJ6L

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.